FiercePharma6d
With new FDA approval, GSK joins Pfizer in the 5-in-1 meningococcal vaccine ring
Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...
Reuters6d
US FDA approves GSK's combo meningococcal vaccine
Feb 15 (Reuters) - The U.S. Food and Drug Administration approved British drugmaker GSK's (GSK.L), opens new tab combination vaccine to protect against meningococcal infection for use in people ...
This is Money4d
GSK gets meningitis vaccine green light from US FDA
US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake of Donald Trump's election for a second term as President. The Food ...
The Motley Fool UK6d
Here’s the dividend forecast for GSK shares through to 2026!
When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...
Mint4d
GlaxoSmithKline Pharmaceuticals shares hit 20% upper circuit as profit jumps fivefold in Q3FY25
Commenting on the results, Bhushan Akshikar, MD of GlaxoSmithKline Pharmaceuticals, highlighted the company’s strategic initiatives in strengthening its market presence and enhancing access to ...
pharmaphorum1d
GSK says $2.2bn settlement resolves most Zantac litigation
GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...
The Motley Fool UK4d
Billionaire’s hedge fund bets big against the GSK share price!
In short, the GSK share price has disappointed shareholders for years. I know, as I have a tiny holding in this business, while my wife has a more meaningful stake. For decades, GSK was my family ...
pharmaphorum2d
GSK bags breakthrough status for bone cancer drug
GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...
CNN5d
Steve Bannon is playing MAGA enforcer from the outside. Is the White House listening?
Through blunt conversations and terse texting exchanges, Steve Bannon, the populist strategist and nationalist firebrand, tries to keep tabs on the inner workings of the White House. His inquiries ...
pharmaphorum1d
GSK plans phase 3 for hepatitis B drug bepirovirsen, despite efficacy drop
GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.
Wired3d
Steven Levy
WIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is ...